Table 3. Prevalence of FSD determined by CVFSFI cutoff values among groups (n = 596, %).

Group	n	Low desire	Arousal disorder	Lubrication disorder	Orgasm disorder	Sexual pain	FSD
Cervicitis
Yes	159	42.8	37.1	47.8	26.4	19.5	49.7
No	437	32.0	34.3	42.8	30.0	20.8	41.2
P value		0.015	0.529	0.276	0.397	0.723	0.064
CIN
Yes	121	42.1	44.6	48.8	32.2	15.7	66.7
No	475	33.1	32.6	42.9	28.2	21.7	43.3
P value		0.061	0.014	0.250	0.382	0.145	0.011
Cervical polyps
Yes	50	40.0	48.0	60.0	34.0	16.0	52.0
No	546	34.4	33.9	42.7	28.6	20.9	42.7
P value		0.429	0.045	0.018	0.418	0.413	0.203
Cervical nabothian cyst
Yes	15	33.3	20.0	53.3	26.7	33.3	53.3
No	581	34.9	35.5	43.9	29.1	20.1	43.2
P value		0.897	0.215	0.467	0.838	0.211	0.434
Cervical hypertrophy
Yes	38	44.7	36.8	50.0	28.9	21.1	47.4
No	558	34.2	34.9	43.7	29.0	20.4	43.2
P value		0.189	0.813	0.451	0.991	0.927	0.615
Cervical submucosal uterine fibroids
(No statistical analysis)
Yes	5	80.0	60.0	60.0	40.0	40.0	60.0
No	591	34.5	34.9	44.0	28.9	20.3	43.3
Cervical genital warts
(No statistical analysis)
Yes	3	100	100	33.3	33.3	100	66.7
No	593	34.6	34.9	44.2	29.0	20.6	43.3
non-malignant cervical diseases
Yes	303	43.2	41.6	51.2	30.0	18.8	51.8
No	293	26.3	28.3	36.9	28.0	22.2	34.8
P value		<0.01	<0.01	<0.01	0.582	0.308	<0.01
Total	596	34.9	35.1	44.1	29.0	20.5	43.5

CVFSFI: the Chinese version of the Female Sexual Function Index. CIN: cervical intraepithelial neoplasia.